Back to Search Start Over

Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan.

Authors :
Hu TH
Su WW
Yang CC
Yang CC
Kuo WH
Chen YY
Yeh YH
Chen SS
Tsao YY
Chen KM
Yan SL
Lai JH
Yao CD
Lim CH
Jen HH
Yeh YP
Chen SL
Chen HH
Chen SC
Source :
American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2021 Oct; Vol. 78 (4), pp. 511-519.e1. Date of Electronic Publication: 2021 May 01.
Publication Year :
2021

Abstract

Rationale & Objective: Hemodialysis facilities are high-risk environments for the spread of hepatitis C virus (HCV). Eliminating HCV from all dialysis facilities in a community may be achieved more effectively under a collaborative care model.<br />Study Design: Quality improvement study of multidisciplinary collaborative care teams including nephrologists, gastroenterologists, and public health practitioners.<br />Setting & Participants: All dialysis patients in Changhua County, Taiwan were treated using an interdisciplinary collaborative care model implemented within a broader Changhua-Integrated Program to Stop HCV Infection (CHIPS-C).<br />Quality Improvement Activities: Provision of an HCV care cascade to fill 3 gaps, including screening and testing, diagnosis, and universal direct-acting antiviral (DAA) treatment implemented by collaborating teams of dialysis practitioners and gastroenterologists working under auspices of Changhua Public Health Bureau.<br />Outcome: Outcome measures included quality indicators pertaining to 6 steps in HCV care ranging from HCV screening to treatment completion to cure.<br />Analytical Approach: A descriptive analysis.<br />Results: A total of 3,657 patients from 31 dialysis facilities were enrolled. All patients completed HCV screening. The DAA treatment initiation rate and completion rate were 88.9% and 94.0%, respectively. The collaborative care model achieved a cure rate of 166 (96.0%) of 173 patients. No virologic failure occurred. The cumulative treatment ratios for patients with chronic HCV infection increased from 5.3% before interferon-based therapy (2017) to 25.6% after restricted provision of DAA (2017-2018), and then to 89.1% after universal access to DAA (2019).<br />Limitations: Unclear impact of this collaborative care program on incident dialysis patients entering dialysis facilities each year and on patients with earlier stages of chronic kidney disease.<br />Conclusions: A collaborative care model in Taiwan increased the rates of diagnosis and treatment for HCV in dialysis facilities to levels near those established by the World Health Organization.<br /> (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1523-6838
Volume :
78
Issue :
4
Database :
MEDLINE
Journal :
American journal of kidney diseases : the official journal of the National Kidney Foundation
Publication Type :
Academic Journal
Accession number :
33940114
Full Text :
https://doi.org/10.1053/j.ajkd.2021.03.017